JP2023540240A5 - - Google Patents
Info
- Publication number
- JP2023540240A5 JP2023540240A5 JP2023513672A JP2023513672A JP2023540240A5 JP 2023540240 A5 JP2023540240 A5 JP 2023540240A5 JP 2023513672 A JP2023513672 A JP 2023513672A JP 2023513672 A JP2023513672 A JP 2023513672A JP 2023540240 A5 JP2023540240 A5 JP 2023540240A5
- Authority
- JP
- Japan
- Prior art keywords
- compounds
- dotatate
- lutetium
- octreotate
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063071138P | 2020-08-27 | 2020-08-27 | |
| US63/071,138 | 2020-08-27 | ||
| PCT/IB2021/000589 WO2022043754A2 (en) | 2020-08-27 | 2021-08-27 | Radiopharmaceutical and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540240A JP2023540240A (ja) | 2023-09-22 |
| JP2023540240A5 true JP2023540240A5 (enExample) | 2024-09-04 |
Family
ID=80352743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513672A Pending JP2023540240A (ja) | 2020-08-27 | 2021-08-27 | 放射性薬剤および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11439714B2 (enExample) |
| EP (1) | EP4204011A4 (enExample) |
| JP (1) | JP2023540240A (enExample) |
| KR (1) | KR20240121161A (enExample) |
| CN (1) | CN116528904A (enExample) |
| AU (1) | AU2021330382A1 (enExample) |
| CA (1) | CA3190855A1 (enExample) |
| TW (1) | TW202227143A (enExample) |
| WO (1) | WO2022043754A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018204872A2 (en) * | 2017-05-05 | 2018-11-08 | Fusion Pharmaceuticals Inc. | Igf-1r monoclonal antibodies and uses thereof |
| JP2023539990A (ja) | 2020-07-13 | 2023-09-21 | ポイント バイオファーマ インコーポレイテッド | 放射性薬剤および方法 |
| WO2023164769A1 (en) * | 2022-03-02 | 2023-09-07 | Point Biopharma, Inc. | Radiopharmaceutical and methods |
| CN115015441B (zh) * | 2022-07-14 | 2023-08-18 | 原子高科股份有限公司 | 一种测定镥[177Lu]氧奥曲肽注射液中稳定剂含量的方法 |
| WO2025171492A1 (en) | 2024-02-14 | 2025-08-21 | Alpha-9 Oncology Inc. | Stable radiopharmaceutical compositions and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1096278A (en) | 1913-08-25 | 1914-05-12 | American Radiator Co | Service-outlet fitting for pneumatic cleaning systems. |
| US6066309A (en) | 1996-02-02 | 2000-05-23 | Rhomed Incorporated | Post-labeling stabilization of radiolabeled proteins and peptides |
| US6358245B1 (en) | 1998-02-19 | 2002-03-19 | Curon Medical, Inc. | Graphical user interface for association with an electrode structure deployed in contact with a tissue region |
| EP1596705B1 (en) | 2003-02-05 | 2018-09-12 | Arthrocare Corporation | Temperature indicating electrosurgical apparatus |
| CN100418585C (zh) | 2003-07-24 | 2008-09-17 | 伯拉考成像股份公司 | 稳定的放射性药物组合物及制备方法 |
| HK1254404A1 (zh) * | 2015-06-25 | 2019-07-19 | Advanced Accelerator Applications | 治疗过度表达生长抑素受体的神经内分泌肿瘤的方法 |
| CN115089242A (zh) | 2016-05-23 | 2022-09-23 | Ip2Ipo创新有限公司 | 末端执行器和持针器 |
| US10537399B2 (en) | 2016-08-16 | 2020-01-21 | Ethicon Llc | Surgical tool positioning based on sensed parameters |
| US10537394B2 (en) | 2016-12-19 | 2020-01-21 | Ethicon Llc | Hot device indication of video display |
| US20200030466A1 (en) * | 2018-07-25 | 2020-01-30 | Advanced Accelerator Applications (Italy) Srl | Stable, concentrated radionuclide complex solutions |
| US10596276B2 (en) * | 2018-07-25 | 2020-03-24 | Advanced Accelerator Applications (Italy) S.R.L. | Stable, concentrated radionuclide complex solutions |
| WO2020064693A1 (en) * | 2018-09-25 | 2020-04-02 | Advanced Accelerator Applications (Italy) Srl | Combination therapy |
| CN112969675B (zh) * | 2018-10-31 | 2024-12-20 | 意大利国际先进加速器应用有限公司 | 用于合成放射性核素络合物的方法 |
-
2021
- 2021-08-27 CN CN202180053207.3A patent/CN116528904A/zh active Pending
- 2021-08-27 TW TW110131903A patent/TW202227143A/zh unknown
- 2021-08-27 AU AU2021330382A patent/AU2021330382A1/en active Pending
- 2021-08-27 KR KR1020237010574A patent/KR20240121161A/ko active Pending
- 2021-08-27 CA CA3190855A patent/CA3190855A1/en active Pending
- 2021-08-27 WO PCT/IB2021/000589 patent/WO2022043754A2/en not_active Ceased
- 2021-08-27 EP EP21860628.3A patent/EP4204011A4/en active Pending
- 2021-08-27 JP JP2023513672A patent/JP2023540240A/ja active Pending
- 2021-08-30 US US17/461,860 patent/US11439714B2/en active Active
-
2022
- 2022-08-04 US US17/817,542 patent/US20220387637A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1185252C (zh) | 生长激素释放抑制因子肽类 | |
| TWI875842B (zh) | 放射性金屬標定抗體、其製造方法、螯合連接子、及肽修飾抗體 | |
| Liu et al. | A new 18F-heteroaryltrifluoroborate radio-prosthetic with greatly enhanced stability that is labelled by 18F–19F-isotope exchange in good yield at high specific activity | |
| JP2008546804A (ja) | 造影剤として用いるためのリガンドの放射性標識ペグ化 | |
| JP2023552180A5 (enExample) | ||
| US12458710B2 (en) | Astatine solution and method for producing same | |
| CN1484534A (zh) | 稳定的放射性药物组合物 | |
| EP0199260A2 (en) | Boronic acid adducts of technetium-99M dioxime complexes | |
| JP2025116040A (ja) | 放射性金属錯体の製造方法 | |
| CN114423421A (zh) | Psma显像剂的制剂 | |
| AU2021265132A1 (en) | Methods for radiolabeling PSMA binding ligands and their kits | |
| EP0096932B1 (en) | Process for making a lyophilized product for use in skeletal imaging | |
| US5262175A (en) | Stabilization of radiopharmaceutical compositions | |
| CN1437486A (zh) | 放射药物的稳定剂 | |
| US20230330276A1 (en) | Formulations and kits for radiotherapy and diagnostic imaging | |
| Bubenshchikov et al. | The impact of zirconium‐89 solution formulation on the efficiency of [89Zr] Zr‐deferoxamine synthesis | |
| EP1401507A2 (en) | Stabilization of radionuclide-containing compositions | |
| JP5264500B2 (ja) | 薬剤をα−粒子エミッターによって放射標識するための安定化組成物および方法 | |
| WO2022225006A1 (ja) | β線を放出する核種で標識されたヒト化抗体 | |
| CN120733077A (zh) | 药物组合物及其制备方法与药物制剂 | |
| WO2023171617A1 (ja) | 電解酸化反応による放射標識アリール化合物の製造方法 | |
| EP4516780A1 (en) | Method for producing radioactive metal complex | |
| TW202515624A (zh) | 用於治療碳酸酐酶ix陽性疾病之方法之放射性標記化合物 | |
| TW202345915A (zh) | 放射藥物及方法 | |
| HK40066248A (en) | Method for producing radioactive metal complex |